China Pharma Holdings (CPHI) Cash & Equivalents: 2009-2025
Historic Cash & Equivalents for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to $300,000.
- China Pharma Holdings' Cash & Equivalents fell 58.26% to $300,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $300,000, marking a year-over-year decrease of 58.26%. This contributed to the annual value of $626,879 for FY2024, which is 55.97% down from last year.
- Per China Pharma Holdings' latest filing, its Cash & Equivalents stood at $300,000 for Q3 2025, which was down 52.00% from $625,032 recorded in Q2 2025.
- China Pharma Holdings' 5-year Cash & Equivalents high stood at $4.9 million for Q4 2021, and its period low was $300,000 during Q3 2025.
- In the last 3 years, China Pharma Holdings' Cash & Equivalents had a median value of $739,337 in 2024 and averaged $829,461.
- In the last 5 years, China Pharma Holdings' Cash & Equivalents skyrocketed by 594.97% in 2022 and then plummeted by 68.59% in 2023.
- Quarterly analysis of 5 years shows China Pharma Holdings' Cash & Equivalents stood at $4.9 million in 2021, then crashed by 58.22% to $2.0 million in 2022, then fell by 29.86% to $1.4 million in 2023, then plummeted by 55.97% to $626,879 in 2024, then slumped by 58.26% to $300,000 in 2025.
- Its last three reported values are $300,000 in Q3 2025, $625,032 for Q2 2025, and $412,688 during Q1 2025.